Bicycle Therapeutics plc Soared
Bicycle Therapeutics plc (BCYC:NASDAQ) rocketted at $48.69, a gain of 16.8%. On Wed, Oct 06, 2021, BCYC:NASDAQ touched a New 2-Week Intraday High of $45.8. The stock got featured on our News Catalysts scanner on Thu, Oct 07, 2021 at 01:54 PM in the 'BIOTECH' category. From Wed, Sep 22, 2021, the stock recorded 40.00% Up Days and 45.45% Green Days
The share price of the company has been moving sideways in recent weeks.
About Bicycle Therapeutics plc (BCYC:NASDAQ)
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops which stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical need.
Top 10 Gainers:
- Camber Energy, Inc. (CEI:NYSEMKT), 95.93%
- Merus N.V. (MRUS:NASDAQ), 37.45%
- New Fortress Energy LLC (NFE:NASDAQ), 25.51%
- Aehr Test Systems (AEHR:NASDAQ), 22.41%
- PEDEVCO Corp. (PED:NYSEMKT), 21.47%
- BRCN (BRCN:NASDAQ), 20.44%
- TKNO (TKNO:NASDAQ), 20.08%
- Altisource Portfolio Solutions S.A. (ASPS:NASDAQ), 18.33%
- Bicycle Therapeutics plc (BCYC:NASDAQ), 16.76%
- Q&K International Group Limited (QK:NASDAQ), 16.68%